Prof. Dr. Mehmet Akif Yeşilipek

  • Uzmanlık Alanları: Kemik iliği nakli, Talasemi, Lösemiler, Kemik iliği yetmezlikleri, Pediatrik kit, Pediatrik hematolog
Eğitim ve Uzmanlık
Ondokuz Mayıs Üniversitesi Tıp Fakültesi - Tıp Eğitimi
Ondokuz Mayıs Üniversitesi Çocuk Sağlığı ve Hastalıkları ABD - Uzmanlık
Akdeniz Üniversitesi Tıp Fakültesi - Pediatrik Hematoloji - Doçentlik
Bahçeşehir Üniversitesi Tıp Fakültesi - Pediatrik Hematoloji - Profesör
 
Mesleki Üyelikler
Member of Turkish Foundation of Pediatrics
Member of Turkish Society of Hematology
Member of European Haematology Association
Member of Akdeniz Thalassemia Society
Member of Akdeniz Hemophilia Society
Member of Turkish Pediatric Oncology Group
Member of Turkish Pediatric Hematology
Member of European Group for Blood and Bone Marrow Transplantation
Member of American Society of Hematology

 

SCI Kapsamındaki Uluslararası Hakemli Dergilerde Çıkan Yayınlar

 

1.Yeşilipek M.A, Standart and Low Birth Weight Formula Compared for Effects on Growth of Preterm Infants, The Turkish Journal of Pediatrics, 34:31-36, 1992.

 

2. Yeşilipek M.A, Lüleci G, Oygür N, Berker S, Yeğin O. A case of Juvenile Chronic Myeloid Leukemia with XX/XXX Mosoicism, The Turkish  Journal of Pediatrics, 34:251-254,1992.

 

3. Yeşilipek M.A, Bircan İ, Oygür N, Ertuğ H, Yeğin O, Gür Güven A. Growth and Sexual Maturation in Children with Beta Thalassemia Major, Haematologica , 78:30-33 , 1993.

 

4.Yeşilipek M.A, Lüleci G, Velipaşaoğlu S, Berker S, Yeğin O. " Monosomy 7 Myelodysplasia in childhood", Acta Haematologica 92: 36-38, 1994.

 

5.Yeşilipek  M.A, Karadoğan İ, Ündar L,  "Bernard-Soulier Syndrome: A Flow cytometric analysis of the membrane GP-Ib expression" , The Turkish Journal of Pediatrics, 38: 375-379, 1996.

 

6.Yeşilipek M.A, Yeğin Olcay, "Interferon Alfa Therapy for Refractory Idiopathic Thrombocytopenic Purpura in Children " , The Turkish Journal of Pediatrics, 39: 173–176, 1997.

 

7. Yeşilipek M.A,  Hazar V, Yeğin O. L-Carnitine treatment in beta thalassemia major, Acta Haematologica, 100:162–163, 1998.

8. Hazar V, Ongun H, Yeşilipek M.A, Yeğin O. Failure of Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor in a Patient with Kostmann Syndrome, The Turkish Journal of Pediatrics, 41: 117–120, 1999.  

9. Yeşilipek M.A, Hazar V, Küpesiz A, Yeğin O.  Peripheral Stem Cell Transplantation in a Child with Amegakaryocytic Thrombocytopenia, Bone Marrow Transplant, 26 (5) : 569–70, 2000.

 

10. Oygür N, Tunga M, Mumcu Y, Yeşilipek M.A, Gura A, Coşkun M, Yeğin O. Thrombopoietin levels of thrombocytopenic term and preterm newborns with infection, Am J Perinatol,  Aug;18(5): 279–86, 2001.

 

11. Yeşilipek M.A,  Hazar V, Küpesiz A, Kızılörs A, Uğuz A, Yeğin O. Peripheral blood stem cell transplantation in children with beta thalassemia. Bone Marrow Transplant, 28 (11): 1037–40, 2001.

 

12. Keser I., Güzeloğlu-Kayışlı Ö., Yeşilipek A., Özeş O.N., Lüleci G. Hb Antalya  Codons 3-5 ( Leu-Thr-ProSer-Asp-Ser).. A new unstable variant leading to chronic macrocytic anemia and high HbA2. Hemoglobin 25(4) : 369-373,2001.

 

13. Birben E., Öner C., Öner R., Mergen H., Yeşilipek M.A., Gümrük F., Gürgey A., Altay Ç. Severe β Thalassemia in frameshift Codon 6 (-A) Homozygotes: Effects of haplotype on phenotype. Hemoglobin 25(4): 441-445, 2001.

 

14. Karaüzüm SB, Hazar V, Açikbas I, Gelen T, Yessilipek MA, Lüleci G. Existence of acute lymphoblastic leukemia and osteosarcoma in a child. J Pediatr Hematol Oncol. 2002 Oct;24(7):572-4.

 

15. Hazar V, Kansoy S, Kupesız A, Aksoylar S, Kantar M, Yeşilipek A. High dose acyclovir and pre-emptive ganciclovir in prevention of cytomegalovirus disease in pediatric patients following peripheral stem cell transplantation. Bone Marrow Transplant 33 : 931-935, 2004.

 

16. Keser I., Sanlioglu A.D., Manguoglu E., Guzeloglu Kayisli O., Nal N., Sargin F., Yesilipek A., Simsek M., Mendilcioglu I., Canatan D., Luleci G. Moleculer Analysis of Beta-Thalassemia in Antalya. Acta Haematologica, 111:205-210, 2004.

 

17. Hazar V, Berber Z, Peştereli E, Coşkun M, Yeşilipek A, Karpuzoğlu G, Yegin O. Clinical importance of circulating and cellular expression levels of Fas and Fas ligand in pediatric patients with lymphoproliferative malignancies. Pediatric Hematology and Oncology, 22: 247-256, 2005.

 

18. Tezcan G, A.Küpesiz, A.Yeşilipek, V.Hazar, GD Aksu, C.Özkaynak, G.Özbilim. Embryonic rhabdomyosarcoma presenting as endobronchial tumor in an adolescent. Pediatric Blood and Cancer, 44, 689-690, 2005.

 

19. Z.Çetin, S.Berker Karaüzüm, A.Küpesiz,V.Hazar, M.A.Yeşilipek, G.Lüleci. Lethal AML after stem cell transplantation in a child with DEB unresponsive Fanconi anemia. Haema,8:136-139, 2005.

 

20. Ö.Güzeloglu-Kayışlı, İ.Keser, O.N.Özeş, D.Canatan, A.Yeşilipek, G.Lüleci. Compound heterozygosity for two beta chain variants: the mildly unstable Hb Tyne (codon 5 Pro--- Ser) and HbS (codon 6 Glu--Val) . Turk J Haematol, 22:37-40, 2005 .

 

21. Sargin CF, Nal N, Manguoglu AE, Keser I, Mendilcioglu I, Yesilipek A, Luleci G. The phenotypic effect of Hb G-Coushatta [beta22 (B4) Glu-Ala] and association with IVS.II.1(G-A)inaTurkishfamily. Genet Couns.  2005;16(3):307-8.

 

22.  N.Nal, A.E.Manguoglu, C.F. Sargın, İ.Keser, A. Küpesiz, A.Yeşilipek, G.Lüleci. Two rare mutations in Turkey: IVS.130 (G-C) and IVS 848 (C-A). Clinical and Laboratory Hematology, 27.274–277, 2005.

 

23. Hazar V, Ugur A, Colak D, Saba R, Tezcan G, Kupesiz A, Karadogan I, Gultekin M, Yesilipek A, Undar L. Cytomegalovirus antigenemia and outcomes of patients undergoing allogeneic peripheral blood stem cell transplantation: effects of long-term high-dose acyclovir prophylaxis and preemptive ganciclovirtreatment. Jpn J Infect Dis. 2006 Aug;59(4):216-21.

 

24. Toptas B, Baykal A, Yesilipek A, Isbir M, Kupesiz A, Yalcin O, Baskurt OK. L-carnitine deficiency and red blood cell mechanical impairment in beta-thalassemia major. Clin Hemorheol Microcirc. 2006;35(3):349-57.

 

25. Tezcan G, Kupesiz A, Ozturk F, Ogunc D, Gultekin M, Yesilipek A, Hazar V. Episodes of fever and neutropenia in children with cancer in a tertiary care medical center in Turkey. Pediatr Hematol Oncol. 2006 Apr-May;23(3):217-29.

 

26.Cetin Z,Tezcan G,Karauzum SB,Kupesiz A,Manguoglu A E, Yesilipek A, Luleci G, Hazar V. Donor Cell-derived Acute Myeloblastic Leukemia After Allogeneic Peripheral Blood Hematopoietic Stem Cell Transplantation for Juvenile Myelomonocytic Leukemia. J Pediatr Hematol Oncol. 2006 Nov;28(11):763-767.

 

27. Yesilipek MA. Stem cell transplantation in hemoglobinopathies. Hemoglobin 2007;31(2):251-6.

 

28. Artac H , Coskun M , Karadogan I , Yegin O , Yesilipek A. Transferrin receptor in proliferation of T lymphocytes in infants with iron deficiency. International Journal Of Laboratory Hematology 29 (4): 310-315 Aug 2007.

 

29. Dundar U, Kupesiz A, Ozdem S, Gilgil E, Tuncer T, Yesilipek A, Gultekin M. Bone metabolism and mineral density in patients with beta-thalassemia major.

Saudi Med J. 2007 Sep;28(9):1425-9.

 

 

30. Keser I, Manguoglu E, Kayisli O, Yesilipek A, Luleci G. Combination of Hb Knossos [Cod 27 (G-T)] and IVSII-745 (C-G) in a Turkish patient with beta-thalassemia major. Genet Test. 2007 Fall;11(3):228-30.

 

31. Ozdem S, Kupesiz A, Yesilipek A. Plasma homocysteine levels in patients with beta-thalassaemia major. Scand J Clin Lab Invest. 2008;68(2):134-9.

 

32. Kardelen F, Tezcan G, Akcurin G, Ertug H, Yesilipek A. Heart rate variability in patients with thalassemia major. Pediatr Cardiol. 2008;29:935-9.

 

33. Yesilipek MA, Tezcan G, Germeshausen M, Kupesiz A, Uygun V, Hazar V. Unrelated cord blood transplantation in children with severe congenital neutropenia. Pediatr Transplant. 2009 Sep;13(6):777-81.

 

34. Hazar V, Gungor O, Guven AG, Aydin F, Akbas H, Gungor F, Tezcan G, Akman S, Yesilipek A. Renal function after hematopoietic stem cell transplantation in children. Pediatr Blood Cancer. 2009 Aug;53(2):197-202.

 

35. Akay A, Dragomir A, Yardimci A, Canatan D, Yesilipek A, Pogue BW. A data-mining approach for investigating social and economic geographical dynamics of beta-thalassemia's spread. IEEE Trans Inf Technol Biomed. 2009 Sep;13(5):774-80.

 

36. Dursun O, Erişir S, Yeşilipek A. Visceral childhood leishmaniasis in southern Turkey: experience of twenty years. Turk J Pediatr. 2009 Jan-Feb;51(1):1-5.

 

37. Uygun V, Karasu GT, Ogunc D, Yesilipek A, Hazar V. Piperacillin/tazobactam versus cefepime for the empirical treatment of pediatric cancer patients with neutropenia and fever: a randomized and open-label study. Pediatr Blood Cancer. 2009 Oct;53(4):610-4.

 

38. Cesaro S, Hirsch HH, Faraci M, Owoc-Lempach J, Beltrame A, Tendas A, Baltadakis I, Dalle JH, Koc Y, Toporski J, Styczynski J, Yesilipek MA, Heinz W, Caniglia M, Rascon J, Fauser AA, Michallet M, Lopez-Corral L, Neuburger S, Tridello G, Einsele H; European Group for Blood and Marrow Transplantation. Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study. Clin Infect Dis. 2009 Jul 15;49(2):233-40.

 

39. Dursun O, Hazar V, Karasu GT, Uygun V, Tosun O, Yesilipek A. Prognostic factors in pediatric cancer patients admitted to the pediatric intensive care unit. J Pediatr Hematol Oncol. 2009 Jul;31(7):481-4.

 

40. Yesilipek MA, Karasu GT, Kupesiz A, Uygun V, Hazar V. Better posttransplant outcome with fludarabine based conditioning in multitransfused fanconi anemia patients who underwent peripheral blood stem cell transplantation. J Pediatr Hematol Oncol. 2009 Jul;31(7):512-5.

 

41. Aydın F, Tezcan G, Güngör O, Cengiz AK, Hazar V, Akman S, Güven AG, Yeşilipek A, Akbaş H, Güngör F. Can serum cystatin C reflect the glomerular filtration rate accurately in pediatric patients under chemotherapeutic treatment? A comparative study with Tc-99m DTPA two-plasma sample method. Nucl Med Commun. 2010 Apr;31(4):301-6.

 

42. Kavakli K, Yesilipek A, Antmen B, Aksu S, Balkan C, Yilmaz D, Kupesiz A, Sasmaz I, Lindgren P, Mesterton J. The value of early treatment in patients with haemophilia and inhibitors. Haemophilia. 2010 May;16(3):487-94.

 

43. Keser I, Yesilipek A, Canatan D, Luleci G . Abnormal hemoglobins associated with the beta-globin gene in Antalya province, Turkey. Turkish Journal Of Medical Sciences 2010;40 (1):127-131.   

 

44.  Yesilipek MA, Karasu G, Kazik M, Uygun V, Ozturk Z. Posttransplant oral iron-chelating therapy in patients with beta-thalassemia major.  Pediatr Hematol Oncol. 2010 Aug;27(5):374-9.

 

45. Hazar V, Karasu GT, Uygun V, Akcan M, Küpesiz A, Yesilipek A. Childhood acute lymphoblastic leukemia in Turkey: factors influencing treatment and outcome: a single center experience. J Pediatr Hematol Oncol. 2010 Nov;32(8):e317-22.

 

46. Duman O, Arayici S, Fettahoglu C, Eryilmaz N, Ozkaynak S, Yesilipek A, Hazar V. Neurocognitive function in patients with β-thalassemia major. Pediatr Int. 2011 Aug;53(4):519-23.

 

47. Yesilipek MA, Karasu G, Erçelen N, Uygun V, Akcan M, Kupesiz A, Hazar V. Successful hematopoietic SCT from non-identical twins to two sisters with β-thalassemia major by using preimplantation genetic diagnosis and HLA typing. Bone Marrow Transplant. 2011 Dec;46(12):1581-2.

 

48. Mendilcioglu I, Yakut S, Keser I, Simsek M, Yesilipek A, Bagci G, Luleci G. Prenatal diagnosis of β-thalassemia and other hemoglobinopathies in southwestern Turkey. Hemoglobin. 2011;35(1):47-55.

 

49. Bilgen T, Arikan Y, Canatan D, Yeşilipek A, Keser I. The association between intragenic SNP haplotypes and mutations of the beta globin gene in a Turkish population. Blood Cells Mol Dis. 2011 Mar 15;46(3):226-9.

 

50. Karasu GT, Yesilipek MA, Karauzum SB, Uygun V, Manguoglu E, Kupesiz A, Hazar V. The value of donor lymphocyte infusions in thalassemia patients at imminent risk of graft rejection following stem cell transplantation. Pediatr Blood Cancer. 2012 Mar;58(3):453-8.

 

51. Zülfikar B, Aydogan G, Salcioglu Z, Oner AF, Kavakli K, Gursel T, Zülfikar H; FEIBA Investigators Team. Efficacy of FEIBA for acute bleeding and surgical haemostasis in haemophilia A patients with inhibitors: a multicentre registry in Turkey. Haemophilia. 2012 May;18(3):383-91.

 

52. Styczynski J, Balduzzi A, Gil L, Labopin M, Hamladji RM, Marktel S, Yesilipek MA, Fagioli F, Ehlert K, Matulova M, Dalle JH, Wachowiak J, Miano M, Messina C, Diaz MA, Vermylen C, Eyrich M, Badell I, Dreger P, Gozdzik J, Hutt D, Rascon J, Dini G, Peters C; European Group for Blood and Marrow Transplantation Pediatric Diseases Working Party. Risk of complications during hematopoietic stem cell collection in pediatric sibling donors: a prospective European Group for Blood and Marrow Transplantation Pediatric Diseases Working Party study. Blood. 2012 Mar 22;119(12):2935-42.

 

53. Fernandes JF, Rocha V, Labopin M, Neven B, Moshous D, Gennery AR, Friedrich W, Porta F, Diaz de Heredia C, Wall D, Bertrand Y, Veys P, Slatter M, Schulz A, Chan KW, Grimley M, Ayas M, Gungor T, Ebell W, Bonfim C, Kalwak K, Taupin P, Blanche S, Gaspar HB, Landais P, Fischer A, Gluckman E, Cavazzana-Calvo M; Eurocord and Inborn Errors Working Party of European Group for Blood and Marrow Transplantation. Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood? Blood. 2012 Mar 22;119(12):2949-55.

 

54. Aydinok Y, Unal S, Oymak Y, Vergin C, Türker ZD, Yildiz D, Yesilipek A. Observational study comparing long-term safety and efficacy of Deferasirox with Desferrioxamine therapy in chelation-naïve children with transfusional iron overload. Eur J Haematol. 2012 May;88(5):431-8.

 

55. Cetin Z, Yakut S, Karadogan I, Kupesiz A, Timuragaoglu A, Salim O, Tezcan G, Alanoglu G, Ozbalci D, Hazar V, Yesilipek MA, Undar L, Luleci G, Berker S. Aberrations of chromosomes 9 and 22 in acute lymphoblastic leukemia cases detected by ES-fluorescence in situ hybridization. Genet Test Mol Biomarkers. 2012 May;16(5):318-23.

 

 

 

56. de Paula EV, Kavakli K, Mahlangu J, Ayob Y, Lentz SR, Morfini M, Nemes L, Šalek SZ, Shima M, Windyga J, Ehrenforth S, Chuansumrit A; 1804 (adept(TM)1) Investigators. Recombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: a randomized controlled trial. J Thromb Haemost. 2012 Jan;10(1):81-9.

 

57. Uygun V, Tayfun F, Akcan M, Karasu GT, Kupesiz A, Hazar V, Yeşilipek A. Quality of life assessment in hematopoietic stem cell transplantation performed on thalassemia major patients. Pediatr Hematol Oncol. 2012 Aug;29(5):461-71.

 

58. Yesilipek AM, Akcan M, Karasu G, Uygun V, Kupesiz A, Hazar V. Successful unrelated bone marrow transplantation in two siblings with alpha-mannosidosis. Pediatr Transplant. 2012 Nov;16(7):779-82.

 

59. Efe E, Işler A, Sarvan S, Başer H, Yeşilipek A. Complementary and alternative medicine use in children with thalassaemia. J Clin Nurs. 2012 Aug 21.

 

60. Yesilipek MA, Ertem M, Cetin M, Öniz H, Kansoy S, Tanyeli A, Anak S, Kurekci E, Hazar V. HLA-matched family hematopoetic stem cell transplantation in children with beta thalassemia major: the experience of the Turkish Pediatric Bone Marrow Transplantation Group. Pediatr Transplant. 2012 Dec;16(8):846-51.

 

61. Powell J, Martinowitz U, Windyga J, Di Minno G, Hellmann A, Pabinger I, Maas Enriquez M, Schwartz L, Ingerslev J; LipLong Study Investigators. Efficacy and safety of prophylaxis with once-weekly BAY 79-4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients. A randomised, active-controlled, double-blind study. Thromb Haemost. 2012 Nov;108(5):913-22.

 

62. Daikeler T, Labopin M, Ruggeri A, Crotta A, Abinun M, Hussein AA, Carlson K, Cornillon J, Diez-Martin JL, Gandemer V, Faraci M, Lindemans C, O'Meara A, Mialou V, Renard M, Sedlacek P, Sirvent A, Socié G, Sora F, Varotto S, Sanz J, Voswinkel J, Vora A, Yesilipek MA, Herr AL, Gluckman E, Farge D, Rocha V. New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of EBMT. Blood. 2012 Dec 17. [Epub ahead of print].

 

63. ROVÓ A, ALJURF M, CHİODİ S, et al; Late Effects Working Party of the EBMT. Ongoing graft-versus-host disease is a risk factor for azoospermia after allogeneic hematopoietic stem cell transplantation: a survey of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Haematologica. 2013 Mar;98(3):339-45

 

64. Kocabaş A, Kardelen F, Ertuğ H, Aldemir-Kocabaş B, Tosun Ö, Yeşilipek A, Hazar V, Akçurin G. Assessment of early-onset chronic progressive anthracycline cardiotoxicity in children: different response patterns of right and left ventricles. Pediatr Cardiol. 2014 Jan;35(1):82-8.

 

65. Elalfy M, Wali YA, Qari M, Al Damanhouri G, Al-Tonbary Y, Yazman D, Al Hawsawi Z, Karakas Z, Kilinc Y, Yesilipek MA, Badr M, Elsafy U, Salama M, Abdel Rahman Y, Shebl S, Stilman A, Toiber Temin N, Tricta F. Deviating from safety guidelines during deferiprone therapy in clinical practice may not be associated with higher risk of agranulocytosis. Pediatr Blood Cancer. 2014 May;61(5):879-84.

 

66. Pennell DJ, Porter JB, Piga A, Lai Y, El-Beshlawy A, Belhoul KM, Elalfy M, Yesilipek A, Kilinç Y, Lawniczek T, Habr D, Weisskopf M, Zhang Y, Aydinok Y; CORDELIA study investigators. A 1-year randomized controlled trial of deferasirox vs deferoxamine for myocardial iron removal in β-thalassemia major (CORDELIA). Blood. 2014 Mar 6;123(10):1447-54.

 

67. Sayar E, Uygun DF, Islek A, Hazar-Sayar E, Akkaya B, Vignoli M, Gambineri E, Yesilipek MA, Artan R. Langerhans cell histiocytosis in IPEX syndrome: Possible role for natural regulatory T cells? Pediatr Allergy Immunol. 2014 Mar 16

 

68. Lalezari S, Coppola A, Lin J, Enriquez MM, Tseneklidou-Stoeter D, Powell J, Ingerslev J; LIPLONG Investigators. Patient characteristics that influence efficacy of prophylaxis with rFVIII-FS three times per week: a subgroup analysis of the LIPLONG study. Haemophilia. 2014 May;20(3):354-61.

 

69. Aldemir-Kocabaş B, Tezcan-Karasu G, Bircan I, Bircan O, Aktaş-Samur A, Yeşilipek MA. Evaluating the Patients with Thalassemia Major for Long-Term Endocrinological Complications After Bone Marrow Transplantation. Pediatr Hematol Oncol. 2014 May 22.

 

70. Kahraman S, Beyazyurek C, Yesilipek MA, Ozturk G, Ertem M, Anak S, Kansoy S, Aksoylar S, Kuşkonmaz B, Oniz H, Slavin S, Karakas Z, Tac HA, Gulum N, Ekmekci GC. Successful haematopoietic stem cell transplantation in 44 children from healthy siblings conceived after preimplantation HLA matching. Reprod Biomed Online. 2014 Sep;29(3):340-51.

 

71. Yildirim AT, Güneş BT, Oymak Y, Yaman Y, Ozek G, Cart O, Yeşilipek A, Vergin C. Congenital amegakaryocytic thrombocytopenia: three case reports from patients with different clinical diagnoses and somatic abnormalities. Blood Coagul Fibrinolysis. 2014 Sep 3.

 

72. Uygun V, Daloglu H, Karasu G, Yeşilipek A. Photopheresis long after the initiation of chronic graft versus host in a child. Transfus Apher Sci. 2014 Oct;51(2):172-4.

 

73. Pennell DJ, Porter JB, Piga A, Lai YR, El-Beshlawy A, Elalfy M, Yesilipek A, Kilinç Y, Habr D, Musallam KM, Shen J, Aydinok Y; on behalf of the CORDELIA study investigators. Sustained improvements in myocardial T2* over 2 years in severely iron-overloaded patients with beta thalassemia major treated with deferasirox or deferoxamine. Am J Hematol. 2014 Oct 27. doi: 10.1002/ajh.23876.

 

74. Uygun V, Daloglu H, Karasu G, Hazar V, Yeşilipek A. Safety and Outcomes of Extracorporeal Photopheresis With the Therakos Cellex System for Graft-Versus-Host Disease in Pediatric Patients. J Pediatr Hematol Oncol. 2014 Nov 4.

 

75. Aydinok Y, Porter JB, Piga A, Elalfy M, El-Beshlawy A, Kilinç Y, Viprakasit V, Yesilipek A, Habr D, Quebe-Fehling E, Pennell DJ. Prevalence and Distribution of Iron Overload in Patients with Transfusion-dependent Anemias Differs across Geographic Regions: Results from the CORDELIA Study. Eur J Haematol. 2014 Nov 24.

 

76. Celmeli F, Turkkahraman D, Uygun V, la Marca G, Hershfield M, Yesilipek A.  A successful unrelated peripheral blood stem cell transplantation with reduced intensity-conditioning regimen in a patient with late-onset purine nucleoside phosphorylase deficiency. Pediatr Transplant. 2014 Dec 17.

 

77. Tucunduva L, Volt F, Cunha R, Locatelli F, Zecca M, Yesilipek A, Caniglia M, Güngör T, Aksoylar S, Fagioli F, Bertrand Y, Addari MC, de la Fuente J, Winiarski J, Biondi A, Sengeloev H, Badell I, Mellgren K, de Heredia CD, Sedlacek P, Vora A, Rocha V, Ruggeri A, Gluckman E; Eurocord and the EBMT Paediatric working party. Combined cord blood and bone marrow transplantation from the same human leucocyte antigen-identical sibling donor for children with malignant and non-malignant diseases. Br J Haematol. 2014 Dec 18.